Two Sigma Advisers’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,100
| Closed | -$510K | – | 2588 |
|
|
2025
Q2 | $510K | Buy |
+4,100
| New | +$522K | ﹤0.01% | 1744 |
|
|
2025
Q1 | – | Sell |
-134,800
| Closed | -$19.4M | – | 2548 |
|
|
2024
Q4 | $19.4M | Buy |
134,800
+8,500
| +7% | +$1.22M | 0.04% | 327 |
|
|
2024
Q3 | $18.8M | Buy |
126,300
+102,100
| +422% | +$14.6M | 0.04% | 331 |
|
|
2024
Q2 | $3.05M | Buy |
+24,200
| New | +$3.79M | 0.01% | 979 |
|
|
2023
Q3 | – | Sell |
-4,500
| Closed | -$637K | – | 2544 |
|
|
2023
Q2 | $637K | Buy |
+4,500
| New | +$722K | ﹤0.01% | 1720 |
|
|
2022
Q1 | – | Sell |
-2,900
| Closed | -$768K | – | 2877 |
|
|
2021
Q4 | $768K | Buy |
+2,900
| New | +$781K | ﹤0.01% | 1699 |
|
|
2021
Q2 | – | Sell |
-8,200
| Closed | -$1.59M | – | 2651 |
|
|
2021
Q1 | $1.59M | Buy |
8,200
+6,400
| +356% | +$1.31M | ﹤0.01% | 1386 |
|
|
2020
Q4 | $345K | Sell |
1,800
-18,300
| -91% | -$3.33M | ﹤0.01% | 2002 |
|
|
2020
Q3 | $2.97M | Buy |
20,100
+11,900
| +145% | +$1.7M | 0.01% | 965 |
|
|
2020
Q2 | $1.01M | Buy |
+8,200
| New | +$965K | ﹤0.01% | 1573 |
|
|
2019
Q4 | – | Sell |
-5,900
| Closed | -$452K | – | 2453 |
|
|
2019
Q3 | $452K | Buy |
5,900
+1,900
| +48% | +$166K | ﹤0.01% | 1754 |
|
|
2019
Q2 | $344K | Sell |
4,000
-3,000
| -43% | -$204K | ﹤0.01% | 1958 |
|
|
2019
Q1 | $414K | Sell |
7,000
-2,900
| -29% | -$167K | ﹤0.01% | 1864 |
|
|
2018
Q4 | $522K | Buy |
+9,900
| New | +$581K | ﹤0.01% | 1752 |
|
|
2017
Q4 | – | Sell |
-37,000
| Closed | -$1.42M | – | 2353 |
|
|
2017
Q3 | $1.42M | Sell |
37,000
-26,000
| -41% | -$1.09M | ﹤0.01% | 1357 |
|
|
2017
Q2 | $2.61M | Buy |
63,000
+30,300
| +93% | +$1.15M | 0.01% | 1065 |
|
|
2017
Q1 | $1.15M | Sell |
32,700
-9,700
| -23% | -$307K | ﹤0.01% | 1513 |
|
|
2016
Q4 | $1.31M | Sell |
42,400
-5,600
| -12% | -$173K | 0.01% | 1413 |
|
|
2016
Q3 | $1.45M | Sell |
48,000
-2,000
| -4% | -$60.4K | 0.01% | 1174 |
|
|
2016
Q2 | $1.37M | Buy |
50,000
+700
| +1% | +$17.9K | 0.01% | 1023 |
|
|
2016
Q1 | $1.32M | Buy |
49,300
+9,200
| +23% | +$225K | 0.01% | 1001 |
|
|
2015
Q4 | $1.13M | Buy |
40,100
+8,100
| +25% | +$234K | 0.01% | 974 |
|
|
2015
Q3 | $894K | Buy |
32,000
+26,500
| +482% | +$958K | 0.01% | 1053 |
|
|
2015
Q2 | $227K | Buy |
+5,500
| New | +$201K | ﹤0.01% | 1710 |
|
|
2014
Q4 | – | Sell |
-31,400
| Closed | -$625K | – | 2719 |
|
|
2014
Q3 | $625K | Sell |
31,400
-12,200
| -28% | -$257K | ﹤0.01% | 1407 |
|
|
2014
Q2 | $994K | Sell |
43,600
-40,200
| -48% | -$716K | 0.01% | 1195 |
|
|
2014
Q1 | $1.08M | Sell |
83,800
-88,900
| -51% | -$1.27M | 0.01% | 1115 |
|
|
2013
Q4 | $2.35M | Sell |
172,700
-6,300
| -4% | -$75.2K | 0.02% | 666 |
|
|
2013
Q3 | $1.99M | Buy |
179,000
+101,500
| +131% | +$1.01M | 0.02% | 643 |
|
|
2013
Q2 | $639K | Buy |
+77,500
| New | +$651K | 0.01% | 1157 |
|
Other funds holding RGEN
UCFA
CIP
Two Sigma Advisers's RGEN Position: Q3 2025 in Review
Two Sigma Advisers sold out of Repligen (RGEN) in Q3 2025, closing a stake of 4,100 shares — an estimated $510K sold.
Two Sigma Advisers first reported a position in RGEN in Q2 2013 and held it in 30 quarters. The position peaked at $19.4M in Q4 2024. 451 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.
- Two Sigma Advisers reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 4,100 Repligen shares in Q3 2025, an estimated $510K.
- Two Sigma Advisers first reported a position in Repligen in Q2 2013 and held it in 30 quarters.
- Two Sigma Advisers's Repligen position peaked at $19.4M in Q4 2024.
- 451 funds tracked by Wall St. Rank held Repligen as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.